socalTECH

SEPTEMBER 8, 2011

Thousand Oaks-based biotech giant Amgen has backed a developer of therapeutic antibodies, via its venture capital arm, Amgen Ventures. Other investors in the round were ARCH Venture Partners, Canaan Partners, MPM Capital, Healthcare Ventures, Alexandria Real Estate Equities, and Zenyaku Kogyo. READ MORE>>.

Thousand Oaks 150

Thousand Oaks Venture Capital Equity Capital 150

socalTECH

APRIL 24, 2012

Amgen Ventures , the venture capital arm of Thousand Oaks-based Amgen , has re-upped on an investment in a biopharmaceuticals developing microRNA-based treatments for cardiovascular and muscle disease. and Broadview Ventures. miRagen is based in Boulder, Colorado.

Thousand Oaks 150

Thousand Oaks Venture Capital Invest Capital 150

socalTECH

APRIL 24, 2012

George Rathmann , the founding CEO of Thousand Oaks biotech giant Amgen , has died, the company announced late Monday evening. Rathman helped secure Amgen's venture capital funding and guide Amgen to its IPO, as well as growing the company to one of the largest biotech firms in the world.

Thousand Oaks 150

Thousand Oaks Guide Venture Capital Capital 150

socalTECH

JANUARY 10, 2014

Thousand Oaks-based Atara Biotherapeutics announced this morning that it is in a second close of its Series B funding round, bringing its total raised in the funding to $52M. amgen lifescience disease renal capital venture biotherapeutics atara' READ MORE>>.

Thousand Oaks 147

Thousand Oaks Capital Funding Invest 147

socalTECH

JULY 2, 2010

Thousand Oaks-based Ceres , a developer of biofuel crop technology, has raised another $20M in funding, according to a regulatory filing from the firm Friday. Tags: warburg capital venture clean cleantech energy biofuel ceres. Source of the new funding was not disclosed. The filing indicates the round came from five investors.

Thousand Oaks 150

Thousand Oaks Equity Funding Capital 150

socalTECH

NOVEMBER 7, 2013

Thousand Oaks-based ImmunGene , a startup biotech company developing antibody-based, protein therapeutics for treating cancer, said today that it has raised $9M in a Series A funding, to advance its early stage development products. immungene venture capital biotech biotechnology cancer therapeutics' READ MORE>>.

Thousand Oaks 164

Thousand Oaks UCLA Venture Capital Equity 164

socalTECH

SEPTEMBER 26, 2012

Thousand Oaks-based Xirrus , the developer of high speed, high performance wireless networking hardware, has raised another big chunk of financing, saying today that it has raised $23.5M in a Series E funding round.

Networking 153

Networking Thousand Oaks Sales Capital 153

socalTECH

AUGUST 31, 2011

Amgen Ventures , the venture capital arm of Thousand Oaks-based Amgen , has backed the developer of a biopharmaceutical aimed at treating irritable bowel syndrome, kidney disease, and diabetes.

Thousand Oaks 150

Thousand Oaks Venture Capital Capital Funding 150

socalTECH

JULY 2, 2014

San Diego-based Ocean Aero , a developer of unmanned, autonomous marine vehicles, has scored funding from Thousand Oaks-based Teledyne , the companies said this morning. investment strategic capital venture marine ocean ship robot autonomous robotic oceanaero aero' Financial terms of the investment were not disclosed.

Thousand Oaks 147

Thousand Oaks Invest San Diego Design 147

socalTECH

APRIL 12, 2010

Thousand Oaks-based Nexsan , a developer of data storage systems, has delayed its IPO, according to its underwriter, Thomas Weisel Partners. The firm's IPO was being underwritten by Thomas Weisel Partners, Lazard Capital Markets, Needham & Company, and Morgan Keegan & Company.

Thousand Oaks 145

Thousand Oaks Marketing Capital Develop 145

socalTECH

MARCH 2, 2010

Thousand Oaks-based Teledyne Technologies announced today that it has acquired a minority interest in Optical Alchemy , a Nashua, New Hampshire-based designer and manufacturer of ultra-light electro optical gimbal systems. Tags: defense optical investment capital venture alchemy teledyne. READ MORE>>.

Invest 150

Invest Thousand Oaks Design Capital 150

socalTECH

NOVEMBER 25, 2009

Thousand Oaks-based Xirrus , a developer of Wi-Fi networking hardware, has raised another $20M in funding, according to a regulatory filing from the firm today. Xirrus has previously raised funding from US Venture Partners, August Capital, Canaan Partners, and QuestMark Partners. READ MORE>>.

Thousand Oaks 145

Thousand Oaks Funding Networking Platform 145

socalTECH

JULY 9, 2012

Thousand Oaks-based wireless equipment maker Xirrus appears to have raised $18.4M According to the filing, representatives of US Venture Partners, August Capital, Alta Partners, and Canaan Partners all have board seats. more in a funding round, part of an ongoing $25.3M funding, according to a regulatory filing by the company.

Thousand Oaks 140

Thousand Oaks Funding Capital Company 140

socalTECH

MAY 8, 2012

The venture capital arm of Thousand Oaks-based Amgen has placed more funding into one of its portfolio companies, Sutro Biopharma , which is working on developing a scalable biochemical protein synthesis platform aimed at cancer therapeutics. Sutro said it has raised $16.5M

Thousand Oaks 140

Thousand Oaks Invest Venture Capital Platform 140

socalTECH

JULY 8, 2010

Thousand Oaks-based Ceres , a developer of biofuels crop technology, said Thursday that it has completed a private offering of convertible preferred stock. Tags: ceres venture capital biotech lifescience biofuel energy cleantech clean crop seed. Ceres is developing improved seed varieties--including. READ MORE>>.

Thousand Oaks 140

Thousand Oaks Venture Capital Design Activity 140

socalTECH

MAY 23, 2011

Thousand Oaks-based Ceres , the developer of seeds aimed at producing renewable, biomass feedstocks for the biofuels industry, has filed for an IPO. and Barclays Capital. and Barclays Capital. The firm's IPO is being underwritten by Goldman, Sachs & co., The firm's IPO is being underwritten by Goldman, Sachs & co.,

Thousand Oaks 140

Thousand Oaks .Net Capital Marketing 140

socalTECH

JANUARY 18, 2011

Thousand Oaks-based Xirrus , the venture backed developer of Wi-Fi equipment headed by Dirk Gates, said today that it has deployed its products at the Madison School District in Rexburg, Idaho. Xirrus is venture backed by August Capital, Canaan Partners, InterWest, QuestMark Partners, and US Venture Partners. READ MORE>>.

Thousand Oaks 140

Thousand Oaks Education Capital Product 140

socalTECH

JULY 16, 2010

Still on tap for an IPO are Pasadena-based Green Dot , Pasadena-based Genmark Diagnostics , Westlake Village-based Inphi , San Diego-based Fallbrook Technologies , Los Angeles-based GameFly , San Diego-based Trius Therapeutics , City of Industry-based NewEgg , and Thousand Oaks-based Nexsan.

Westlake Village 145

Westlake Village Woodland Hills Thousand Oaks ReachLocal 145

socalTECH

DECEMBER 1, 2009

Thousand Oaks-based Xirrus confirmed Tuesday that it has raised an additional $20M in funding, bringing the firm's total raised to $80M. Tags: xirrus venture capital fundraising wifi networking hardware. The round was led by InterWest Partners. Khaled Nasr of InterWest Partners joins the company's board along with the funding.

Thousand Oaks 140

Thousand Oaks Funding Venture Capital Networking 140

socalTECH

JANUARY 25, 2012

Thousand Oaks-based Ceres , the developer of seeds to supply the bioenergy and biofuels feedstock business, has set its initial pricing range for its IPO, according to a filing from the company this morning. Barclays Capital, Piper Jaffray, Raymond James, and Simmons & Company International. and $23.00

Pricing 145

Pricing Thousand Oaks Design Capital 145

socalTECH

FEBRUARY 22, 2012

Thousand Oaks-based Ceres , the developer of specialized seeds for the biofuels market, has priced its IPO, saying that it will offer up 5,000,000 shares of its common stock at $13.00 Barclays Capital, PIper Jaffray, Raymond James, and Simmons & Company International. The IPO was underwritten by Goldman, Sachs & CO.,

Pricing 150

Pricing Thousand Oaks Startup Design 150

socalTECH

FEBRUARY 28, 2012

Thousand Oaks-based Ceres , the developer of seed stock for energy crops, said today that it has closed its IPO, selling a total of 5,750,000 shares of its common stock at $13.00 Barclays Capital, Piper Jaffray, Raymond James, and Simmons & Company International. The firm's IPO was underwritten by Goldman Scahs & Co.,

Thousand Oaks 140

Thousand Oaks Southern California Marketing Capital 140

socalTECH

FEBRUARY 11, 2011

The firm, which is based in Northern California but has major operations in Thousand Oaks, said that Elevation will continue to hold $50M in Series B preferred stock in the firm. Move said the moves are part of a plan to "streamline" its capital structure. Move, Inc. ,

Thousand Oaks 140

Thousand Oaks Networking Sites Capital 140

socalTECH

AUGUST 13, 2013

Wilcon said its network now connects Los Angeles, Burbank, Pasadena, Santa Monica, Woodland Hills, Thousand Oaks, Santa Clarita, Long Beach, Irvine, Riverside, Carlsbad and San Diego. Wilcon said it was supported in the deal by Pamlico Capital; financial details of that backing was also not announced. READ MORE>>.

Santa Clarita 147

Santa Clarita Woodland Hills Networking Thousand Oaks 147

socalTECH

MAY 20, 2010

Thousand Oaks-based Ceres , a developer of biofuel crop technology, and Novozymes , a developer of enzymes, said today that the two have entered into a research collaboration around cellulosic biofuel production. Financial details of the partnership were not disclosed.

Thousand Oaks 145

Thousand Oaks Equity Research Product 145

socalTECH

JANUARY 3, 2013

YouMail is led by Alex Quilici, and backed by VantagePoint Capital Partners, the Tech Coast Angels, the Tech Coast Angels ACE Fund, Siemer Ventures, and the CrunchFund. Red Pocket Mobile is based in Thousand Oaks. The two said that Red Pocket Mobile's customers can now access YouMail from any compatible GSM phone.

Tech Coast Angels 138

Tech Coast Angels Thousand Oaks Mobile Services 138

socalTECH

AUGUST 26, 2009

Thousand Oaks-based Xirrus , a developer of Wi-Fi networking hardware, has scored another education customer, the firm announced today. Xirrus is venture backed by August Capital, Canaan Partners, QuestMark Partners, and US Venture Partners. Financial details on the win were not disclosed. READ MORE>>.

Education 133

Education Thousand Oaks Customer Custom 133

socalTECH

APRIL 8, 2014

Thousand Oaks-based drug development company Atara Biotherapeutics announced this morning that it has added Matthew K. Fust as a board member, and hired Mitchall G. Clark as its Chief Regulatory and Quality Assurance Officer. READ MORE>>. atara biotherapeutics renal disease lifescience amgen executive board'

Thousand Oaks 138

Thousand Oaks Invest Capital Funding 138

socalTECH

JANUARY 4, 2019

Atara Biotherapeutics , the biopharmaceuticals firm which has its manufacturing and research efforts based in Thousand Oaks, said on Thursday that its current President and CEO, Isaac Ciechanover, M.D., The company is based in South San Francisco, but was founded in Thousand Oaks and has a large facility in the city.

Thousand Oaks 113

Thousand Oaks Research Invest Capital 113

socalTECH

JANUARY 22, 2010

The latest numbers from the MoneyTree Report from PricewaterhouseCoopers and the National Venture Capital Association (NVCA), based on data from Thomson Reuters, were released this morning, finding that there was $587.8M Tags: venture capital investment quarterly moneytree thomson reuters. invested in Southern California in Q4.

Southern California 154

Southern California Venture Capital Invest Orange County 154

socalTECH

JUNE 29, 2010

Thousand Oaks-based Xirrus , which develops Wi-Fi networking devices, reported today that it has deployed its Wi-Fi arrays at the Corona-Norco Unified School District. The firm is backed by August Capital, Canaan Partners, Interwest, QuestMark, and U.S. Financial impact of the win was not disclosed. READ MORE>>.

Thousand Oaks 140

Thousand Oaks Education Networking Platform 140

socalTECH

OCTOBER 24, 2008

Thousand Oaks-based Xirrus has rolled out a new Wi-Fi array, the firm said earlier this week, the Xirrux XN8. Xirrus is venture backed by August Capital, Canaan Partners, QuestMark Partners, and US Venture Partners. The firm's products are targeted at providing higher bandwidth and coverage than standard Wi-Fi access points.

Thousand Oaks 124

Thousand Oaks Pricing Capital Product 124

socalTECH

SEPTEMBER 27, 2012

In a proof that it's not all social media and e-commerce here in Southern California, number two ranking startup in The Wall Street Journal's ranking of the "Top 50 Startups" is none other than wireless hardware provider Xirrus , based in Thousand Oaks. That list included Laguna Hills-based Glaukos at number 7; Donuts Inc. ,

West Hollywood 145

West Hollywood Thousand Oaks Southern California Journal 145

socalTECH

NOVEMBER 17, 2017

Amgen Ventures , the venture investment arm of Thousand Oaks-based Amgen , is one of the new investors in precision oncology and medicine startup Syapse.

Thousand Oaks 113

Thousand Oaks Funding Software Capital 113

socalTECH

JANUARY 9, 2017

Thousand Oaks-based Amgen is the lead investor in a round for San Francisco- and Bozeman, Montana-based SiteOne Therapeutics , SiteOne said on Friday. SiteOne said it raised $15M in a Series B funding round, which was led b Amgen, and also included Next Frontier Capital and insiders.

Thousand Oaks 100

Thousand Oaks Invest Capital Funding 100

socalTECH

MARCH 8, 2016

Thousand Oaks-based Amgen has made another investment this morning in immunology startup Tizona Therapeutics , via its venture capital arm, Amgen Ventures. Series A investors--including Amgen Ventures--also participated, with investments from MPM Capital, Astellas Venture Management and InterWest Partners. READ MORE>>.

Thousand Oaks 100

Thousand Oaks Funding Venture Capital Invest 100

socalTECH

JANUARY 5, 2017

the founding shareholder and chairman and treasurer of Thousand Oaks-based Amgen , has died, at the age of 90. Bowes--who also founded venture capital firm USVP --died peacefully in his home on December 28th. Bowes, Jr. , Amgen said that "without Bowes, there would be no Amgen".

Thousand Oaks 113

Thousand Oaks Venture Capital Capital Invest 113